Vir Biotechnology, Inc. (VIR) Institutional Ownership
Q1 2026 13F Data|Updated 2026-06-13
✨
Institutional ownership increased this quarter (+38.84 pp), though top 10 holders maintain a highly concentrated 59.0% of institutional value.
Institutional Ownership88.6%$1.2B total value · ▲ +38.84 pp vs prior quarter
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
Smart Money Score79 / 100Bullish
Based on ownership concentration, fund quality, buying/selling activity, conviction signals, and institutional trend.
Institutions & Flow248 holders+32 net flow (+71 / -39)
AI Insights & Key Takeaways
- Positive Institutional Flow (+32)
- Marquee funds including Citadel Advisors Llc and Point72 Asset Management, L.p. maintain significant positions
- Top 10 holders control 59.0% of institutional value
- No Insider Signal
Top Institutional Holders of VIR
Ranked by reported Q1 2026 13F market value
Top 10 Holders
59.0%
Top 25 Holders
78.4%
Share of total reported institutional value in VIR held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 18.0M | $161.3M | +10.2% | 11.163% | 0.00% |
| 2 | ARCH Venture Management, LLC | 12.9M | $115.7M | 0.0% | 8.011% | 17.09% |
| 3 | SB INVESTMENT ADVISERS (UK) LTD | 10.9M | $98.1M | -16.5% | 6.790% |
Quarterly Institutional Activity
Filings activity in VIR during Q1 2026, grouped by how each filer changed its position.
VIR Institutional Ownership by Quarter
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 248 | +15% | 88.58% | +38.84 pp | $1.23B | +78% |
| Q4 2025 | 216 | +4.3% | 49.74% | +6.07 pp | $691M | +14% |
| Q3 2025 | 207 | 1.4% | 43.67% | +3.83 pp | $606M | +9.6% |
| Q2 2025 | 210 | 8.7% | 39.84% | 2.63 pp | $553M | 6.2% |
| Q1 2025 | 230 | +11% | 42.47% | 3.24 pp | $590M | 7.1% |
| Q4 2024 | 208 | +7.8% |
VIR — Frequently Asked Questions
Quick answers to the most common questions about buying VIR stock.
What percentage of VIR is owned by institutions?
Based on Q1 2026 13F filings, institutional ownership of Vir Biotechnology, Inc. stands at 88.6%, held across 248 reporting institutions.
Who is the largest institutional holder of VIR?
BlackRock, Inc. is the largest reported institutional holder of VIR, with approximately 17,998,329 shares worth $0.16B as of Q1 2026.
Is VIR a hedge fund favorite?
Yes — 3 widely-followed marquee investors appear among the top 25 institutional holders of VIR, including CITADEL ADVISORS LLC, Point72 Asset Management, L.P., TWO SIGMA INVESTMENTS, LP.
What is VIR's Smart Money Score?
Our composite Smart Money Score for VIR is 79 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.